ticlopidine has been researched along with Liver Steatosis in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study is an investigation of the association between high on-treatment platelet reactivity to clopidogrel (HTPRC) and hepatosteatosis in patients who had elective stent implantation due to coronary artery disease." | 3.88 | Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation. ( Alper, AT; Barutca, H; Bora Şişman, S; Bozbeyoğlu, E; Çakıllı, Y; Çinier, G; Güzelburç, Ö; Şahin, S; Tekkeşin, Aİ; Velibey, Y; Yıldırımtürk, Ö, 2018) |
| "All three antiplatelet drugs, namely aspirin, ticlopidine and cilostazol, significantly attenuated liver steatosis, inflammation and fibrosis in the CDAA diet group." | 3.74 | Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. ( Abe, Y; Endo, H; Fujita, K; Inamori, M; Iwasaki, T; Kirikoshi, H; Kobayashi, N; Kubota, K; Nagashima, Y; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Wada, K; Yoneda, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velibey, Y | 1 |
| Tekkeşin, Aİ | 1 |
| Barutca, H | 1 |
| Yıldırımtürk, Ö | 1 |
| Bozbeyoğlu, E | 1 |
| Çakıllı, Y | 1 |
| Güzelburç, Ö | 1 |
| Bora Şişman, S | 1 |
| Çinier, G | 1 |
| Şahin, S | 1 |
| Alper, AT | 1 |
| Fujita, K | 1 |
| Nozaki, Y | 1 |
| Wada, K | 1 |
| Yoneda, M | 1 |
| Endo, H | 1 |
| Takahashi, H | 1 |
| Iwasaki, T | 1 |
| Inamori, M | 1 |
| Abe, Y | 1 |
| Kobayashi, N | 1 |
| Kirikoshi, H | 1 |
| Kubota, K | 1 |
| Saito, S | 1 |
| Nagashima, Y | 1 |
| Nakajima, A | 1 |
| Russo, MW | 1 |
| Pierson, J | 1 |
| Narang, T | 1 |
| Montegudo, A | 1 |
| Eskind, L | 1 |
| Gulati, S | 1 |
| Remy, AJ | 1 |
| Heran, B | 1 |
| Galindo, G | 1 |
| Tapie, C | 1 |
| Khemissa, F | 1 |
| Larrey, D | 1 |
| Pistone, AM | 1 |
| Podestà, F | 1 |
| Raviolo, E | 1 |
| Testa, D | 1 |
| Grosso, B | 1 |
| Toselli, P | 1 |
| Nyffeneger, G | 1 |
5 other studies available for ticlopidine and Liver Steatosis
| Article | Year |
|---|---|
Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation.
Topics: Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Fatty Liver; Femal | 2018 |
Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspirin; Cholesterol; Choline Deficiency; Cilostazol; Dietary Fats; D | 2008 |
Coronary artery stents and antiplatelet therapy in patients with cirrhosis.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Fatty Liver; Female; Follow-Up Studies; Gastroi | 2012 |
[A new drug responsible for microvesicular steatosis: ticlopidine].
Topics: Aged; Aged, 80 and over; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans | 1999 |
[Cholestatic fatty liver of probably iatrogenic origin].
Topics: Anticoagulants; Cholestasis, Intrahepatic; Fatty Liver; Female; Humans; Iatrogenic Disease; Middle A | 1986 |